Displaying drugs 126 - 150 of 408 in total
| Name | Weight | Structure | Desription | Categories |
|---|---|---|---|---|
| Guselkumab | 143.6 C6402H9864N1676O1994S42 |  | A monoclonal antibody used to treat moderate to severe plaque psoriasis. | Interleukin Inhibitors |
| Damoctocog alfa pegol | 234.0 | | A recombinant Factor VIII used to treat hemophilia A to control bleeding, perioperative bleeding, and also for prophylaxis of bleeding. | Blood Coagulation Factors / Pegylated agents |
| Antihemophilic factor (recombinant), PEGylated | 284.0 | | For the management of hemophilia A (congenital factor VIII deficiency) [FDA label], . This medication is a human antihemophilic factor indicated in adolescent and adult patients (12 years and older)... | Recombinant Proteins |
| Thyroglobulin | 660.0 |  | For the treatment of hypothyroidism (deficiency in the production of thyroid hormone). | Globulins / Glycoproteins / Iodoproteins |
| Eptifibatide | 831.962 C35H49N11O9S2 | | A peptide-based antagonist for glycoprotein IIb/IIIa used in the medical management of myocardial infarction and as an adjunct to percutaneous coronary intervention. | Platelet Aggregation Inhibitors Excl. Heparin |
| Urofollitropin | 980.162 C42H65N11O12S2 |  | A form of purified human follicle stimulating hormone used to treat infertility in females by inducing follicle development in women without primary ovarian failure. | Gonadotropins |
| Oxytocin | 1007.187 C43H66N12O12S2 |  | A recombinant hormone used to induce or strengthen uterine contractions in pregnant women to aid in labor and delivery or to control postpartum bleeding. | Oxytocin and Analogues |
| Terlipressin | 1227.38 C52H74N16O15S2 | | A drug used to treat bleeding caused by esophageal varices. | Vasopressin and Analogues |
| Icatibant | 1304.54 C59H89N19O13S | | A bradykinin B2 receptor antagonist used to treat acute episodes of swelling and inflammation associated with hereditary angioedema (HAE). | Drugs Used in Hereditary Angioedema |
| Motixafortide | 2159.6 C97H144FN33O19S2 | | A peptide inhibitor of CXCR4 used to mobilize hematopoietic stem cells prior to collection and autologous transplantation in multiple myeloma patients. | Amino Acids, Peptides, and Proteins / Hematopoietic Stem Cell Mobilizer / Peptides |
| Lucinactant | 2470.2 C 126 H 238 N 26 O 22 | | Intended for the prevention of respiratory distress syndrome (RDS) in premature infants at high risk for RDS. | Pulmonary Surfactants |
| Secretin human | 3039.44 C130H220N44O39 |  | A secretin hormone used to stimulate pancreatic or gastric secretions to diagnose exocrine pancreas dysfunction, gastrinoma, and abnormalities in the bile and pancreatic ducts. | Tests for Pancreatic Function |
| Sermorelin | 3357.882 C149H246N44O42S | | For the treatment of dwarfism, prevention of HIV-induced weight loss | Somatropin and Somatropin Agonists / Tests for Pituitary Function |
| Dasiglucagon | 3382.0 C152H222N38O50 | | A glucagon analog used to treat severe hypoglycemia in pediatric and adult patients with diabetes. | Glycogenolytic Hormones |
| Human calcitonin | 3417.9 C151H226N40O45S3 |  | Human calcitonin is indicated for the treatment of Paget's disease in the cases where the use of salmon calcitonin may provoke the generation of high-titer of antibodies. Paget's disease is... | Calcitonin Preparations |
| Salmon calcitonin | 3431.853 C145H240N44O48S2 |  | A synthetic peptide form of calcitonin used to inhibit bone resorption in the treatment of hypercalcemia, osteoporosis, and Paget's disease. | Bone Density Conservation Agents / Bone Density, drug effects / Calcitonin Preparations / Calcium-Regulating Hormones and Agents / Neuropeptides / Peptide Hormones / Thyroid Products |
| Nesiritide | 3464.0 |  | A recombinant natriuretic peptide used for the treatment of patients with acutely decompensated congestive heart failure who have dyspnea at rest or with minimal activity. | Natriuretic Agents / Natriuretic Peptide, Brain / Natriuretic Peptides / Nerve Tissue Proteins |
| Liraglutide | 3751.2 C172H265N43O51 | | A GLP-1 analog used in the management of type 2 diabetes mellitus and prevention of cardiovascular complications associated with diabetes. | Glucagon-like peptide-1 (GLP-1) analogues |
| Teduglutide | 3752.0 C164H252N44O55S | | A glucagon-like peptide-2 (GLP-2) analog used to treat patients with Short Bowel Syndrome (SBS) who require parenteral nutritional support. | Various Alimentary Tract and Metabolism Products |
| Glucagon | 3767.1 C165H249N49O51S1 |  | A form of recombinant glucagon used to treat hypoglycemia in diabetes mellitus and as a part of gastrointestinal imaging procedures. | Glycogenolytic Hormones |
| Abaloparatide | 3961.0 C174H300N56O49 | | A parathyroid hormone-related protein (PTHrP) analog used for the treatment of osteoporosis in patients with a high risk of fracture. | Bone Density Conservation Agents / Parathyroid Hormones and Analogues |
| Vosoritide | 4100.0 C176H290N56O51S3 | | An analogue of C-type naturietic peptide used to promote bone growth in pediatric patients with achondroplasia. | C-type Natriuretic Peptide Analog |
| Teriparatide | 4117.715 C181H291N55O51S2 | | A recombinant parathyroid hormone used for the treatment of osteoporosis. | Bone Density Conservation Agents / Calcium-Regulating Hormones and Agents / Parathyroid Hormones and Analogues / Thyroid Products |
| Exenatide | 4186.6 C184H282N50O60S |  | A GLP-1 agonist used in the management of type 2 diabetes mellitus. | Glucagon-like peptide-1 (GLP-1) analogues |
| Enfuvirtide | 4491.876 C204H301N51O64 |  | An HIV-1 gp41 fusion inhibitor used in patients experiencing HIV-1 replication who are already being treated with other anti-retrovirals. | HIV Envelope Protein gp41 / HIV Fusion Inhibitors / Human Immunodeficiency Virus 1 Fusion Inhibitor / Peptide Fragments |
Displaying drugs 126 - 150 of 408 in total